Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, Moderna (MRNA) has a market cap of $10.14 billion USD. According to our data, Moderna is ranked No.1587 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $10.14 B |
-36.89%
|
| Dec 31, 2024 | $16.08 B |
-58.19%
|
| Dec 29, 2023 | $38.45 B |
-44.63%
|
| Dec 30, 2022 | $69.45 B |
-29.28%
|
| Dec 31, 2021 | $98.19 B |
143.11%
|
| Dec 31, 2020 | $40.39 B |
434.10%
|
| Dec 31, 2019 | $7.56 B |
28.09%
|
| Dec 31, 2018 | $5.90 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 BioNTech
BNTX
|
$23.80 B |
0.001 M
|
Germany
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Novavax
NVAX
|
$1.03 B |
0.000 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
| Market Cap | = | MRNA Stock Price | * | MRNA Shares Outstanding |
| = | $26.24 | * | 0.39 B | |
| = | $10.14 B |